Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma

MeSH terms

• Adult
• Antibodies, Monoclonal, Murine-Derived / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Chemical Fractionation
• Cyclophosphamide / administration & dosage
• Cytarabine / administration & dosage
• Dexamethasone / administration & dosage
• Dose-Response Relationship, Drug
• Doxorubicin / administration & dosage
• Humans
• Kaplan-Meier Estimate
• Lymphoma, Non-Hodgkin / drug therapy*
• Lymphoma, Non-Hodgkin / pathology
• Middle Aged
• Rituximab
• Treatment Outcome
• Vincristine / administration & dosage
• Young Adult